← Eichor
Condition: Gastrointestinal Tumors Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastrointestinal Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
Phase N/A · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07154173Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable
Phase 2 · 1 location(s) · Emory University · NCT06423326The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surger
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT05984485Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02361320Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
NA · 1 location(s) · Fudan University · NCT07272382Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05768503An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
Phase 3 · 1 location(s) · Ruijin Hospital · NCT06339060An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer
Phase 2 · 2 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07589569Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821843A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Phase 1 · 9 location(s) · PAQ Therapeutics, Inc. · NCT07300150DETECT: Target Volume for Rectal Endoluminal Radiation Boosting
Phase N/A · 3 location(s) · Maastricht Radiation Oncology · NCT04927897Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT04485286ALFAOMEGA Master Observational Trial
Phase N/A · 19 location(s) · IFOM ETS - The AIRC Institute of Molecular Oncology · NCT04120935Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Phase N/A · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT05687188Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT07046468Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768Institut Paoli Calmettes Colorectal Cancer Database
Phase N/A · 1 location(s) · Institut Paoli-Calmettes · NCT02869503China Colorectal Cancer Screening Trial 1 (C-Cost1)
NA · 7 location(s) · Zhejiang University · NCT07090291Pilot Study of Pancreatic Cancer Screening
Phase N/A · 1 location(s) · University of California, San Francisco · NCT05058846Development of New Diagnostic Tools in Capsule Endoscopy
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152289Molecular Characterisation of Appendiceal Cancer
Phase N/A · 1 location(s) · The Christie NHS Foundation Trust · NCT05364788Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07177794Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Phase N/A · 2 location(s) · Gene Solutions · NCT06227728The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
NA · 1 location(s) · Huashan Hospital · NCT07369830Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06454383First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
Phase 2 · 1 location(s) · Fudan University · NCT06313970Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
NA · 1 location(s) · Yunnan Cancer Hospital · NCT06735105AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07551466A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Crossignal Therapeutics, Inc. · NCT06598007
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.